Developing a new method to improve molecular simulations for drug discovery
New Generation of General AMBER Force Field for Biomedical Research
['FUNDING_R01'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10915667
This study is working on improving computer simulations to better understand how tiny drug molecules connect with proteins in our bodies, which is important for creating new and better medicines, especially for conditions like cancer.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10915667 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing molecular simulations to better understand how small molecules interact with proteins, which is crucial for drug development. By creating a new generation of force fields, the study aims to improve the accuracy of predicting how drugs bind to their targets. The approach involves using advanced computational techniques to sample molecular interactions more effectively, which could lead to the discovery of more effective drugs. Patients may benefit from this research as it could lead to new treatments for various conditions, including cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that require new drug therapies, particularly those related to cancer treatment.
Not a fit: Patients who are not seeking new drug therapies or those with conditions that are not targeted by this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective drugs for treating diseases by improving the understanding of drug interactions at the molecular level.
How similar studies have performed: Previous research has shown success in improving molecular simulations for drug discovery, indicating that this approach has potential for significant advancements.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, JUNMEI — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: WANG, JUNMEI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.